#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	11908	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2057	571.9	0	.	n	.	0	C451T	SNP	451	451	C	683	683	T	720	T,C	347,352	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	11908	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2057	571.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1416	1416	C	672	C	655	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	11908	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2057	571.9	0	HET	.	.	.	C207T	.	207	207	C	439	439	C	715	C,T	543,152	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22102	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3527	623.4	0	.	n	.	0	T695C	SNP	695	695	T	974	974	C	684	C	674	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22102	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3527	623.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2250	2250	C	670	C	656	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22102	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3527	623.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2324	2324	A	644	A	634	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22102	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3527	623.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2876	2876	C	676	C	659	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22102	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3527	623.4	0	HET	.	.	.	A1638G	.	1638	1638	A	1917	1917	A	680	A,G	337,330	.	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	16	8	blaTEM	861	290	100.0	blaTEM.l15.c30.ctg.1	449	1.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1500	folP	855	855	100.0	folP.l6.c4.ctg.1	1495	99.7	1	SNP	p	R229S	1	.	.	685	687	AGC	983	985	AGC	167;169;172	A;G;C	164;165;167	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4542	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3379	133.7	1	SNP	p	S91F	1	.	.	271	273	TTC	566	568	TTC	158;158;157	T;T;C	157;157;155	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4542	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3379	133.7	1	SNP	p	G95N	0	.	.	283	285	GGC	578	580	GGC	157;154;154	G;G,A;C	156;151,1;153	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4542	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3379	133.7	1	SNP	p	D95G	1	.	.	283	285	GGC	578	580	GGC	157;154;154	G;G,A;C	156;151,1;153	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1320	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1221	107.6	1	SNP	p	G45D	0	.	.	133	135	GGC	406	408	GGC	153;150;151	G;G;C	149;145;150	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	788	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	1053	74.5	0	.	n	.	0	A197.	DEL	197	197	A	598	598	A	182	A,G	177,1	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3880	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2828	135.7	1	SNP	p	D86N	0	.	.	256	258	GAC	452	454	GAC	135;134;136	G;A;C	134;128;134	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3880	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2828	135.7	1	SNP	p	S87R	1	.	.	259	261	CGT	455	457	CGT	134;134;132	C;G;T	134;132;128	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3880	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2828	135.7	1	SNP	p	R87W	0	.	.	259	261	CGT	455	457	CGT	134;134;132	C;G;T	134;132;128	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3880	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2828	135.7	1	SNP	p	R87I	0	.	.	259	261	CGT	455	457	CGT	134;134;132	C;G;T	134;132;128	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3880	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2828	135.7	1	SNP	p	S88P	0	.	.	262	264	TCC	458	460	TCC	132;131;127	T;C;C	128;130;125	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3494	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2666	130.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1537	1539	GGC	175;173;170	G;G;C,A	172;170;162,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3262	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2319	137.4	1	SNP	p	A311V	0	.	.	931	933	GCC	1201	1203	GCC	176;178;177	G;C;C,A	174;178;174,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3262	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2319	137.4	1	SNP	p	I312M	1	.	.	934	936	ATG	1204	1206	ATG	175;175;176	A;T,C;G,C	173;172,1;174,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3262	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2319	137.4	1	SNP	p	T316P	0	.	.	946	948	ACC	1216	1218	ACC	182;180;181	A,G;C,T;C,G	170,1;176,1;174,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3262	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2319	137.4	1	SNP	p	V316T	1	.	.	946	948	ACC	1216	1218	ACC	182;180;181	A,G;C,T;C,G	170,1;176,1;174,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3262	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2319	137.4	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1717	1719	ACC	172;175;174	A;C;C	161;171;170	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3262	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2319	137.4	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1771	1773	GCG	161;161;159	G;C;G	161;157;157	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3262	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2319	137.4	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1771	1773	GCG	161;161;159	G;C;G	161;157;157	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3262	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2319	137.4	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1894	1896	GGT	124;124;122	G,A;G;T,C	114,3;116;112,4	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3262	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2319	137.4	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1903	1905	AGC	113;112;109	A,G;G;C	102,5;111;102	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3262	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2319	137.4	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1921	1923	CCG	102;103;99	C,G,T;C;G	89,3,1;91;82	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4440	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	3145	140.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1634	1636	CCG	156;153;154	C;C,T;G	146;142,8;147	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2000	porA	1146	1146	99.91	porA.l15.c17.ctg.1	1572	123.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	413	413	C	137	C	129	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	180	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	392	14.9	0	.	p	.	0	A251V	NONSYN	751	753	GCG	76	78	GTA	19;19;19	G;T,C;A,G	17;15,2;15,2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	180	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	392	14.9	0	.	p	.	0	S271T	NONSYN	811	813	TCG	136	138	ACT	29;28;27	A,T;C;T	27,1;27;27	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	180	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	392	14.9	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	142	144	GAT	25;24;23	G;A;T	25;23;23	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	180	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	392	14.9	0	.	p	.	0	D276N	NONSYN	826	828	GAT	151	153	AAC	23;23;23	A;A;C	23;23;23	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	180	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	392	14.9	0	.	p	.	0	N277H	NONSYN	829	831	AAC	154	156	CAC	23;23;23	C;A;C	23;23;23	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	180	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	392	14.9	0	.	p	.	0	R307E	NONSYN	919	921	AGA	244	246	GAA	8;8;8	G;A;A	8;8;8	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	180	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	392	14.9	0	.	p	.	0	T311A	NONSYN	931	933	ACA	256	258	GCA	9;9;9	G;C;A	9;8;9	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	180	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	392	14.9	0	.	p	.	0	E312D	NONSYN	934	936	GAA	259	261	GAC	9;9;9	G;A;C	9;9;9	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	180	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	392	14.9	0	.	p	.	0	F314I	NONSYN	940	942	TTC	265	267	ATC	11;11;11	A;T;C	11;11;11	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	180	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	392	14.9	0	.	p	.	0	A316S	NONSYN	946	948	GCG	271	273	TCG	11;12;12	T,C;C;G	10,1;12;11	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	180	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	392	14.9	0	.	p	.	0	V318A	NONSYN	952	954	GTC	277	279	GCC	11;11;11	G;C;C	11;11;10	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	180	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	392	14.9	0	.	p	.	0	G319S	NONSYN	955	957	GGC	280	282	AGC	11;11;11	A;G;C	11;11;11	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	180	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	392	14.9	0	.	p	.	0	G320A	NONSYN	958	960	GGT	283	285	GCC	11;11;11	G;C;C	11;11;11	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	180	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	392	14.9	0	.	p	.	0	G322V	NONSYN	964	966	GGT	289	291	GTT	10;10;10	G;T;T	10;10;10	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2134	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1572	134.3	1	SNP	p	G120K	1	.	.	358	360	AAG	682	684	AAG	172;170;168	A;A;G	167;168;157	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2134	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1572	134.3	1	SNP	p	N121D	0	.	.	361	363	AAC	685	687	AAC	170;170;172	A,G;A;C	161,3;166;165	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2134	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1572	134.3	1	SNP	p	A121N	1	.	.	361	363	AAC	685	687	AAC	170;170;172	A,G;A;C	161,3;166;165	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	7994	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4945	160.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	838	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1138	73.4	1	SNP	p	V57M	1	.	.	169	171	ATG	498	500	ATG	156;157;155	A,T;T;G	152,1;150;151	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
